Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Return on Capital Employed (2018 - 2022)

Historic Return on Capital Employed for Iterum Therapeutics (ITRM) over the last 5 years, with Q3 2022 value amounting to 0.44%.

  • Iterum Therapeutics' Return on Capital Employed fell 1700.0% to 0.44% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.44%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.5% for FY2021, which is 30800.0% down from last year.
  • As of Q3 2022, Iterum Therapeutics' Return on Capital Employed stood at 0.44%, which was down 1700.0% from 0.37% recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Return on Capital Employed ranged from a high of 20.83% in Q2 2020 and a low of 74.99% during Q4 2019
  • Moreover, its 5-year median value for Return on Capital Employed was 0.37% (2022), whereas its average is 3.03%.
  • Per our database at Business Quant, Iterum Therapeutics' Return on Capital Employed plummeted by -741800bps in 2019 and then soared by 776300bps in 2020.
  • Quarter analysis of 5 years shows Iterum Therapeutics' Return on Capital Employed stood at 0.8% in 2018, then crashed by -9220bps to 74.99% in 2019, then skyrocketed by 104bps to 2.64% in 2020, then crashed by -111bps to 0.3% in 2021, then tumbled by -47bps to 0.44% in 2022.
  • Its Return on Capital Employed stands at 0.44% for Q3 2022, versus 0.37% for Q2 2022 and 0.34% for Q1 2022.